Mark Hicar is an Infectious Disease physician affiliated with Jacobs Institute. OpenAlex indexes 96 publications with 1,475 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
3 NIH research awards on record, funded 2012–2025 per NIH RePORTER. The latest:
- Training the Next Generation of Clinician Scientist
State University of New York at Buffalo
FY2025$90,526T35AI089693 - The role of non-broadly neutralizing antibodies targeting gp41 structural epitopes in long term nonprogression of HIV infection
State University of New York at Buffalo
FY2020$390,782R01AI125119 - The role of non-broadly neutralizing antibodies targeting gp41 structural epitopes in long term nonprogression of HIV infection
State University of New York at Buffalo
FY2019$391,089R01AI125119
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Lipshultz, MD
Jacobs Institute
Amit Kandel, MBBS
Jacobs Institute
Drucy Borowitz, MD
Jacobs Institute
Vanessa Barnabei, MD
Jacobs Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”